David Toung
Stock Analyst at Argus Research
(4.15)
# 431
Out of 5,182 analysts
133
Total ratings
63.11%
Success rate
8.74%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $230 → $180 | $154.51 | +16.50% | 1 | Mar 23, 2026 | |
| PFE Pfizer | Upgrades: Buy | $35 | $28.32 | +23.59% | 2 | Mar 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $471.84 | +18.68% | 3 | Feb 6, 2026 | |
| HOLX Hologic | Downgrades: Hold | n/a | $75.65 | - | 3 | Jan 12, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $53.13 | +27.99% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $491.46 | +24.12% | 8 | Oct 29, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $86.63 | +32.75% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $177.83 | +58.57% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $300.74 | - | 4 | Jul 21, 2025 | |
| GFS GLOBALFOUNDRIES | Initiates: Buy | $52 | $43.75 | +18.86% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $277.26 | - | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $9.53 | - | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $208.84 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $214.05 | -41.60% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $173.89 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $347.94 | -2.28% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $884.28 | -24.23% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $90.89 | +65.03% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $935.58 | -10.22% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $70.35 | +56.36% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $273.72 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $331.54 | -6.50% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $452.07 | -29.21% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $102.87 | +31.23% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $139.71 | -46.32% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $59.60 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $120.87 | -8.99% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.27 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $203.49 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $154.03 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $243.04 | -36.22% | 4 | Mar 27, 2020 |
Becton, Dickinson and Company
Mar 23, 2026
Maintains: Buy
Price Target: $230 → $180
Current: $154.51
Upside: +16.50%
Pfizer
Mar 2, 2026
Upgrades: Buy
Price Target: $35
Current: $28.32
Upside: +23.59%
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $471.84
Upside: +18.68%
Hologic
Jan 12, 2026
Downgrades: Hold
Price Target: n/a
Current: $75.65
Upside: -
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $53.13
Upside: +27.99%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $491.46
Upside: +24.12%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $86.63
Upside: +32.75%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $177.83
Upside: +58.57%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $300.74
Upside: -
GLOBALFOUNDRIES
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $43.75
Upside: +18.86%
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $277.26
Upside: -
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $9.53
Upside: -
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $208.84
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $214.05
Upside: -41.60%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $173.89
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $347.94
Upside: -2.28%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $884.28
Upside: -24.23%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $90.89
Upside: +65.03%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $935.58
Upside: -10.22%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $70.35
Upside: +56.36%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $273.72
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $331.54
Upside: -6.50%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $452.07
Upside: -29.21%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $102.87
Upside: +31.23%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $139.71
Upside: -46.32%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $59.60
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $120.87
Upside: -8.99%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $5.27
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $203.49
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $154.03
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $243.04
Upside: -36.22%